GlassScriptPhysician profile
Mark D Bevill
NPI 1487182937
$3,956.07
in general payments reported to CMS, 2019-2025
9 companies · $555 in 2025
The $555 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,183 · 2020: $192 · 2021: $32.62 · 2022: $126 · 2024: $1,867 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639 · Travel and Lodging: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.36 |
| Travel and Lodging | $782.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,194.86 | 2019-2025 | Rezum Generator, Ams 700, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $1,225.20 | 2024 | Aquabeam System |
| C. R. Bard, INC. & Subsidiaries | $155.72 | 2025 | Bard Urinary Drainage Bag |
| Intuitive Surgical, INC. | $145.29 | 2024 | |
| Laborie Medical Technologies Corp. | $107.23 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $60.65 | 2025 | Adstiladrin |
| Hologic Sales and Service, LLC | $29.65 | 2024 | Omni Hysteroscope, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Astrazeneca Pharmaceuticals LP | $23.83 | 2022 | |
| Calyxo, INC. | $13.64 | 2025 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bevill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.